The Lead in Peds: Episode Three

Growing hope: Advancing care for kids with growth disorders

The Lead in Peds: Episode Three

Growing hope: Advancing care for kids with growth disorders

Play and Subscribe

Stream on your favorite podcast app.

Apple Music

Stream and Subscribe

Spotify

Stream and Subscribe

YouTube

Stream and Subscribe

Amazon Music

Stream and Subscribe

Discover More From The Lead in Peds

About the Episode

For children with short stature and rare genetic growth disorders, hope is on the horizon at Children’s National Hospital. Andrew Dauber, MD, MMSc, chief of Endocrinology, and Nathan Kuppermann, MD, MPH, chair of Pediatrics and chief academic officer, sat down to discuss groundbreaking research transforming the field. Hear about the world’s first clinical trial of vosoritide for hypochondroplasia, led by Dr. Dauber, and the design of a precision medicine trial for a single patient. Dr. Dauber and his team are uncovering genetic causes and developing targeted treatments. Learn how these breakthroughs are reshaping pediatric endocrinology and offering new possibilities for families worldwide.

Listen via Apple, Spotify, YouTube or wherever you get your podcasts.

Download Episode Transcript